Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCIG vs Oral Levodopa in Advanced Parkinson's Disease
NCT00660387Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of levodopa + carbidopa in Parkinson's disease (PD), sponsored by AbbVie Inc.. Started Dec 2009; status: completed.
02
Drugs
levodopa + carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00660387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660387.